Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Will cost cuts be enough for Hasbro to thrive in 2024?: https://www.marketbeat.com/logos/articles/med_20231231120706_chartt-has.jpg
Will cost cuts be enough for Hasbro to thrive in 2024?

Global toy and entertainment company Hasbro Inc. (NYSE: HAS) had a weak 2023 as shares fell 17.5% compared to the 24.8% gain for the S&P 500 index. It also underperformed rival Mattel Inc. (NYSE:

Will cost cuts be enough for Hasbro to thrive in 2024?: https://www.marketbeat.com/logos/articles/med_20231231120706_chartt-has.jpg
Will cost cuts be enough for Hasbro to thrive in 2024?

Global toy and entertainment company Hasbro Inc. (NYSE: HAS) had a weak 2023 as shares fell 17.5% compared to the 24.8% gain for the S&P 500 index. It also underperformed rival Mattel Inc. (NYSE:

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech

 

03.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech

 

03.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech

 

03.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg
Analysts suddenly say Google is the place to be in

Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure

Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg
Analysts suddenly say Google is the place to be in

Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure

Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg
Analysts suddenly say Google is the place to be in

Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure

One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg
One fast-food stock is expected to outperform all others in 2024

With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of

One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg
One fast-food stock is expected to outperform all others in 2024

With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of

2 fast-casual restaurants to grab before they get taken out: https://www.marketbeat.com/logos/articles/med_20231231122144_chart-sg2.jpg
2 fast-casual restaurants to grab before they get taken out

The fast-casual dining segment is part of the consumer discretionary sector. The segment is no stranger to acquisitions and mergers. Restaurants that have grown to become iconic fixtures, having

PepsiCo's dividend won't last long in today's market: https://www.marketbeat.com/logos/articles/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg
PepsiCo's dividend won't last long in today's market

Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the

PepsiCo's dividend won't last long in today's market: https://www.marketbeat.com/logos/articles/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg
PepsiCo's dividend won't last long in today's market

Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the

ConAgra is still a value investor’s dream: https://www.marketbeat.com/logos/articles/med_20231231120927_chart2-cag.jpg
ConAgra is still a value investor’s dream

Packaged and frozen foods maker ConAgra Brands Inc. (NYSE: CAG) had a rough 2023, with shares losing 26.19% versus the S&P 500 index performance of 24.8%. The weak macroeconomic environment led to

2 gene-editing stocks reshaping hereditary disease treatments: https://www.marketbeat.com/logos/articles/med_20231231121858_chart-ntla.jpg
2 gene-editing stocks reshaping hereditary disease treatments

Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal Drug Administration (FDA) approved a

4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg
4 reasons to buy Dutch Bros stock over Starbucks

Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO

4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg
4 reasons to buy Dutch Bros stock over Starbucks

Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO

4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg
4 reasons to buy Dutch Bros stock over Starbucks

Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO

New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg
New price targets could erase Cisco's 3.1% dividend yield soon

A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you

New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg
New price targets could erase Cisco's 3.1% dividend yield soon

A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you

New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg
New price targets could erase Cisco's 3.1% dividend yield soon

A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you

New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg
New price targets could erase Cisco's 3.1% dividend yield soon

A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you

Weight Watchers gains from Oprah’s GLP-1 weight-loss: https://www.marketbeat.com/logos/articles/med_20231231120220_charttt-ww.jpg
Weight Watchers gains from Oprah’s GLP-1 weight-loss

Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication and WW International Inc. (NYSE: WW)

Is the Apple Watch ban the tipping point?: https://www.marketbeat.com/logos/articles/med_20231231120446_chartt-aapl.jpg
Is the Apple Watch ban the tipping point?

Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have

Is the Apple Watch ban the tipping point?: https://www.marketbeat.com/logos/articles/med_20231231120446_chartt-aapl.jpg
Is the Apple Watch ban the tipping point?

Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have